Literature DB >> 9285386

Growth hormone and glutamine do not stimulate intestinal adaptation following massive small bowel resection in the rat.

J A Vanderhoof1, K A Kollman, S Griffin, T E Adrian.   

Abstract

BACKGROUND: Certain nutrients and other trophic factors are highly sensitive stimulants of intestinal adaptation following short bowel syndrome. Growth hormone and glutamine in a modified diet have been shown to enhance nutrient absorption in patients with severe short bowel syndrome. However, neither growth hormone nor glutamine is capable of enhancing adaptation in an animal model. This study was conducted to determine if the combination of glutamine and growth hormone could enhance gut adaptation following massive small bowel resection in the rat.
METHODS: Thirty-four male rats received 70% jejunoileal resection. The first group received glycine and rat growth hormone, the second glutamine and rat growth hormone, and the third glycine but no growth hormone.
RESULTS: There was no evidence that the combination of glutamine and growth hormone could enhance mucosal mass, mucosal protein, or mucosal DNA levels relative to the other two control groups of animals. Likewise, sucrase activities were not enhanced by glutamine and growth hormone.
CONCLUSIONS: It is unlikely that the combination of glutamine and growth hormone will be of benefit in the treatment of patients with short bowel syndrome. The results in previous human studies can be alternatively explained by the long-term nonspecific effect of enteral nutrition on gut adaptation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9285386     DOI: 10.1097/00005176-199709000-00016

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  13 in total

1.  Growth hormone stimulates remnant small bowel epithelial cell proliferation.

Authors:  Xin Zhou; Ning Li; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

Review 2.  Somatropin (Zorbtive): in short bowel syndrome.

Authors:  Gillian M Keating; Keri Wellington
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Novel agents in the treatment of intestinal failure: humoral factors.

Authors:  Hua Yang; Daniel H Teitelbaum
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

Review 4.  Intestinal transplantation in children.

Authors:  L Sigurdsson; J Reyes; S A Kocoshis
Journal:  Curr Gastroenterol Rep       Date:  1999-06

Review 5.  Nutritional and pharmacological strategy in children with short bowel syndrome.

Authors:  Michael E Höllwarth; Valeria Solari
Journal:  Pediatr Surg Int       Date:  2021-01-03       Impact factor: 1.827

6.  Short- and long-term effects of small bowel resection: a unique histological study in a piglet model of short bowel syndrome.

Authors:  Prue M Pereira-Fantini; Sarah L Thomas; Guineva Wilson; Russell G Taylor; Magdy Sourial; Julie E Bines
Journal:  Histochem Cell Biol       Date:  2011-01-20       Impact factor: 4.304

7.  Effects of recombinant human growth hormone on enterocutaneous fistula patients.

Authors:  Guo-Sheng Gu; Jian-An Ren; Ning Li; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

8.  Gastric pentadecapeptide BPC 157 and short bowel syndrome in rats.

Authors:  Marko Sever; Robert Klicek; Bozo Radic; Luka Brcic; Ivan Zoricic; Domagoj Drmic; Mihovil Ivica; Ivan Barisic; Spomenko Ilic; Lidija Berkopic; Alenka Boban Blagaic; Marijana Coric; Danijela Kolenc; Hrvoje Vrcic; Tomislav Anic; Sven Seiwerth; Predrag Sikiric
Journal:  Dig Dis Sci       Date:  2008-12-18       Impact factor: 3.199

Review 9.  The pharmacologic treatment of short bowel syndrome: new tricks and novel agents.

Authors:  Matthew L Bechtold; Stephen A McClave; Lena B Palmer; Douglas L Nguyen; Lindsay M Urben; Robert G Martindale; Ryan T Hurt
Journal:  Curr Gastroenterol Rep       Date:  2014

Review 10.  New and emerging therapies for short bowel syndrome in children.

Authors:  Jon A Vanderhoof; Rosemary J Young; Jon S Thompson
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.